Roy de Souza is solving a big problem of our lifetimes: curing solid cancers. BreakBio uses AI/ML to find 30 targets on a patient’s cancer cells from various patient data sets especially mass spectrometry per patient (an industry first). Mass spectrometry provides accurate AI training per patient. It then manufactures a 30 peptide personalized immunotherapy which is also known as a cancer vaccine. Clinical trials in the first indication are starting this year at top academic centres like MD Anderson. Roy received a Masters in Engineering at Oxford, an MBA from the Kellogg School and worked for Elon Musk's first company. He founded ZEDO Inc. that became the 3rd largest ad server in the world and used AI to determine which user sees which ad. He sold ZEDO to Warner Bros Discovery, the world's largest media company which owns CNN and HBO.